UEF0:XETRA:XETRA-UBS Barclays US Liquid Corporates UCITS hedged to EUR A-acc (EUR)

ETF | Others |

Last Closing

USD 17.464

Change

0.00 (0.00)%

Market Cap

USD 0.36B

Volume

302.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The sub-fund aims to track, before expenses, the price and income performance of the Bloomberg Barclays US Liquid Corporates" Index (Total Return) (this sub-fund's Index). Additionally currency hedged share classes aim to reduce the impact of currency fluctuations between their reference currency and the index currency by selling currency forwards at the one-month forward rate in accordance with the hedging methodology of the Index's currency-hedged index variant as referred to in relation to each hedged share class below.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

ETFs Containing UEF0:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.79% 35% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.79% 35% F 42% F
Trailing 12 Months  
Capital Gain 11.61% 40% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.61% 40% F 46% F
Trailing 5 Years  
Capital Gain -7.28% 21% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.28% 21% F 32% F
Average Annual (5 Year Horizon)  
Capital Gain -3.41% N/A N/A 17% F
Dividend Return -3.41% N/A N/A 16% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.43% N/A N/A 73% C
Risk Adjusted Return -40.51% N/A N/A 15% F
Market Capitalization 0.36B 58% F 52% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike